In multiple myeloma cells, LXRs activation enhanced the NK cell-cytotoxicity activity by upregulating the NKG2D ligands, namely, MHC class I polypeptide-related sequence-A (MICA) and MICB respectively (Bilotta et al., 2019). Here, KLRK1 is linked to plasma cell myeloma.